Customer Center
Login | Register


Empowering Labs with Targeted and Syndromic Testing

Respiratory Disease Portfolio


For respiratory infection testing, clinical labs must adapt quickly to changing needs based on seasonal demand, as well as patient age and overall health. With significant overlap of symptoms across infections and an evolving reimbursement landscape, labs must have flexibility in assays to deliver high-quality, cost-effective results.


Whether you need high-volume influenza assays or a broad selection of targets, we can help.


Luminex offers the most scalable, flexible respiratory disease testing portfolio to assist labs with managing the needs of physicians, patients, and the overall healthcare system. Our molecular diagnostic assays allow you to adjust target selection and sample throughput for maximum testing accuracy, cost efficiency, and clinical impact.


Learn more about our respiratory disease testing options:




Which Test is Right for You?
Category Targeted Syndromic
Assay ARIES® Group A Strep Assay ARIES® Flu A/B & RSV Assay ARIES® Bordetella Assay NxTAG® Respiratory Pathogen Panel
Instruments ARIES® Systems ARIES® Systems ARIES® Systems MAGPIX® (NxTAG‑enabled)
Pathogens 1 3 2 21
Turnaround Time
2 hours 2 hours 2 hours 5 hours
Hands-on Time
3 minutes
per sample
3 minutes
per sample
3 minutes
per sample
7 minutes
per 24 samples
Throughput Low – Medium Low – Medium Low – Medium High
  Learn More Learn More Learn More Learn More




Respiratory Disease Resources:


For respiratory testing, there is no “one size fits all”MLO Online

Adapting Your Respiratory Testing Algorithm in a Changing Reimbursement LandscapeWebinar

Flu Season Hits Epidemic LevelsLuminex Blog

Erasmus MC Publication Reports Evaluation of ARIES® Flu A/B & RSV AssayLuminex Blog

Expert Commentary: A Clinician’s Perspective on Flexible TestingCase Study

Flexible Respiratory Pathogen Testing: Why Clinical Laboratories No Longer Have To SettleWhite Paper